home / stock / vrtx / vrtx articles

VRTX Articles, Vertex Pharmaceuticals Incorporated - From 11/07/23

Stock Information
Company Name: Vertex Pharmaceuticals Incorporated
Stock Symbol: VRTX
Market: NASDAQ
Website: vrtx.com
Menu
VRTX VRTX Quote VRTX Short VRTX News VRTX Articles VRTX Message Board
Get VRTX Alerts

News, Short Squeeze, Breakout and More Instantly...
US Stocks Eye Longest Winning Streak In 2 Years, Oil Tumbles: What's Driving Markets Tuesday? | Benzinga

U.S. stocks are attempting to post the longest streak of consecutive positive sessions in over two years. As of midday trading in New York, both th...
These Analysts Revise Their Forecasts On Vertex Pharmaceuticals After Q3 Results | Benzinga

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported upbeat earnings for its third quarter, while sales missed estimates. Vertex Pharmaceuti...

S&P 500, Nasdaq Set To Break 6-Day Rally Today? Traders Await Fed Cues, Analyst Says Seasonal Rally Has Started With Gusto | Benzinga

Sentiment appears to have dipped after a six-session winning streak. Stock futures indicate a modestly lower opening on Tuesday as small and mid-ca...

Stocks Fight To Extend Winning Streak, Treasury Yields Rise: What's Driving Markets Monday? | Benzinga

The beginning of the week brought mixed performance for stocks on Wall Street, with the major indices trading close to the flatline during midday t...
US Stocks Set To Extend 5-Day Winning Streak Today? Traders Anxiously Watch Fed Speech, Climbing Bond Yields | Benzinga

The market looks set to extend last week’s gains, with the stock futures holding up early Monday ahead of a slew of earnings reports mostly f...

Here's How Much $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today | Benzinga

Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 10 years by 9.66% on an annualized basis producing an average annual...

Questions Surround Vertex/CRISPR's Sickle Cell Gene Therapy As FDA AdComm Meeting Approaches | Benzinga

The FDA's Cellular, Tissue, and Gene Therapies Advisory Committee will meet next week, Tuesday, 31 October, to discuss whether V...
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings | Benzinga

In the current market session, Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) stock price is at $361.86, after a 0.81% decrease. However, over the past ...

Vertex Pharmaceuticals, Gilead Sciences And 2 Other Stocks Insiders Are Selling | Benzinga

The Nasdaq 100 closed lower by over 200 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell share...

Mixed Signals For CRISPR Therapeutics, Analyst Weighs Barriers, Potential Sales For Sickle Cell Therapy | Benzinga

Cantor Fitzgerald has downgraded CRISPR Therapeutics AG (NASDAQ: CRSP) to Neutral from Overweight, noting that its sickle cell ...
Previous 10 Next 10